FDA Tentatively Approves Generic Femara

Drug Industry Daily
A A
The FDA tentatively approved Mylan Pharmaceuticals’ generic version of breast cancer treatment Femara, the company announced last week.

To View This Article:

Login

Subscribe To Drug Industry Daily